Indivior PLC
LSE:INDV
Indivior PLC
Other Operating Expenses
Indivior PLC
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Indivior PLC
LSE:INDV
|
Other Operating Expenses
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Other Operating Expenses
-£180m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AstraZeneca PLC
LSE:AZN
|
Other Operating Expenses
-$964m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Other Operating Expenses
-$4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
43%
|
CAGR 10-Years
24%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Indivior PLC's Other Operating Expenses?
Other Operating Expenses
2m
USD
Based on the financial report for Mar 31, 2024, Indivior PLC's Other Operating Expenses amounts to 2m USD.